Pharmaceuticals

Future Outlook of the Non-Opioid Pain Patch Market: Growth, Trends, and Emerging Opportunities Explored

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the non-opioid pain patch market size evolved in recent years?

Recently, the non-opioid pain patch market has seen robust growth and is expected to expand further, rising from $3.48 billion in 2024 to $3.66 billion in 2025, representing a compound annual growth rate (CAGR) of 5.1%. The significant growth in the past can be credited to factors such as a surge in chronic pain instances, patients’ inclination towards non-invasive therapies, enhanced ingredient formulations, an increase in sports-related injuries, and worries about opioid dependency.

What are the predictions for the non-opioid pain patch market size in the coming years?

Over the coming years, the non-opioid pain patch market is predicted to experience a strong surge in growth, augmenting its size to $4.5 billion by 2029, with a compound annual growth rate (CAGR) of 5.3%. Factors contributing to the expansion during the forecast period include rising levels of investment in research and development, an increase in healthcare spending, a conducive regulatory context, growing consumer education and awareness, along with a growing elderly population. Notable emerging trends during the projection period consist of wireless and intelligent patch technologies, the incorporation of organic ingredients, compatibility with wearable tech, patches that are biodegradable and favorable towards the environment, with a focus on prolonging effects.

Get your non-opioid pain patch market report here!

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

What key factors are fueling the growth of the non-opioid pain patch market?

The increasing incidence of chronic pain is anticipated to fuel the expansion of the non-opioid pain patch market in the future. Chronic pain is a kind of severe long-lasting pain or a pain that accompanies another medical condition. Non-opioid pain patches are utilized for providing relief from mild to moderate pain and addressing headaches, muscle soreness, arthritis, backaches, and other forms of pain. For example, data from Eurostat, a government agency based in Luxembourg, revealed in November 2023 that in 2022, more than one-third or 36.1% of people within the EU stated they had a long-term (chronic) health condition. Hence, the escalating incidence of chronic pain is driving the growth of the non-opioid pain patch market.

How is the global non-opioid pain patch market divided into key segments?

The non-opioid pain patch market covered in this report is segmented –

1) By Patch: Lidocaine Patches, Diclofenac Patches, Capsaicin Patches, Ketoprofen Patches, Other Patches

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

3) By Indication: Musculoskeletal Pain, Neuropathic Pain

Subsegments:

1) By Lidocaine Patches: 5% Lidocaine Patch, Other Concentrations

2) By Diclofenac Patches: 1.3% Diclofenac Patch, Other Concentrations

3) By Capsaicin Patches: 8% Capsaicin Patch, Other Concentrations

4) By Ketoprofen Patches: 5% Ketoprofen Patch, Other Concentrations

5) By Other Patches: Combination Patches, Herbal Extract Patches, Other Non-Opioid Patches

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12230&type=smp

Who are the key firms paving the way for growth in the non-opioid pain patch market?

Major companies operating in the non-opioid pain patch market include Hisamitsu Pharmaceutical Co., Inc., Teikoku Pharma USA, Inc., Purdue Pharma L.P., Noven Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Grünenthal GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Medtronic plc, Abbott Laboratories, Bayer AG, Iroko Pharmaceuticals, LLC, Scilex Pharmaceuticals Inc., Zosano Pharma Corporation, Adynxx Inc., BioElectronics Corporation, NeuroMetrix Inc., Virpax Pharmaceuticals Inc., Eli Lilly and Company, Novartis AG, Amgen Inc., DURECT Corporation

Which trends are expected to transform the non-opioid pain patch market?

In the realm of non-opioid pain patches, product innovation has become a major trend with increasing popularity. Main players in this industry are designing and introducing unique products in order to solidify their standing. The Mentholatum Company Inc., a UK Health-focused product manufacturer, for instance, entered the scene in June 2022 with a brand-new product: The Deep Relief Actiflex Patch. This is a treatment patch that does not contain any medication, instead having a cooling hydrogel content, which offers quick cooling and relieving effects as the water evaporates from the skin. The patch is effective in providing relief from joint or muscle aches and pains.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12230

What regions are contributing significantly to the growth of the non-opioid pain patch market?

North America was the largest region in the non-opioid pain patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-opioid pain patch market report during the forecast period. The regions covered in the non-opioid pain patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Medical Tourism Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-tourisms-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Nebulizers Global Market Opportunities And Strategies To 2030: COVID 19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/nebulizers-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: